Table 3.
Clinical presentation of patients with lung cancer after HTX.
| Parameter | Lung Cancer after HTX (n = 41) |
|---|---|
| Symptomatic | |
| Symptomatic finding, n (%) | 26 (63.4%) |
| Shortness of breath, n (%) | 26 (63.4%) |
| Fatigue, n (%) | 22 (53.7%) |
| Cough, n (%) | 22 (53.7%) |
| Rust-colored sputum, n (%) | 19 (46.3%) |
| Loss of weight, n (%) | 19 (46.3%) |
| Night sweats, n (%) | 16 (39.0%) |
| Infection, n (%) | 15 (36.6%) |
| Fever, n (%) | 14 (34.1%) |
| Loss of appetite, n (%) | 14 (34.1%) |
| Hoarseness, n (%) | 6 (14.6%) |
| Asymptomatic | |
| Asymptomatic finding, n (%) | 15 (36.6%) |
| Incidental detection in chest X-ray, n (%) | 12 (29.3%) |
| Incidental detection in chest computed tomography, n (%) | 3 (7.3%) |
| Smoking status | |
| Smoking before HTX, n (%) | 40 (97.6%) |
| Smoking after HTX, n (%) | 35 (85.4%) |
Abbreviations: HTX = heart transplantation; n = number.